Anti-CS1 monoclonal antibody (elotuzumab biosimilar)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMA1002-100uL

  • Size

    100uL

  • Price

    $320

1
Elotuzumabb (brand name Empliciti), is a humanized monoclonal antibody developed by Bristol-Myers Squibb. It was approved by FDA in 2014 for treatment of relapsed multiple myeloma (MM). The antibody targets SLAMF7 (CD319), activating natural cytotoxicity of NK cells and enhancing ADCC against cancer cells.
target SLAMF7
gene id 57823
alias CS1, CD319, SLAMF7, CRACC
reactivity Human
host Humanized
clonality Monoclonal
clone number BMS-901608, HuLuc63, PDL-063, PDL063
iso type IgG1
formulation Purified from cell culture supernatant by affinity chromatography; Kept in PBS (pH 7.4) with 0.1% BSA, 0.1% ProClin 300 and 50% Glycerol
applications ELISA, Flow Cytometry
dilution ELISA 1:1000
shipping With ice packs
storage Store at -20°C for at least 1 year. Avoid multiple freeze-thaw cycles.

PRODUCT

  • SKU

    DMA1002-100uL

  • Size

    100uL

  • Price

    $320

1